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Summary
Nasal colonization plays an important role in the pathogenesis 
ofStaphylococcus aureus infections. To identify characteristics
associated with colonization, we studied a cross-section of a
well-described cohort of HIV-seropositive and-seronegative active
and former drug users considered at risk for staphylococcal
infections. Sixty percent of the 217 subjects were Hispanic, 36%
were women, 25% actively used injection drugs, 23% actively used
inhalational drugs, 23% received antibiotics, and 35% were
HIV-seropositive. Forty-one percent of subjects had positive nasal
cultures for S. aureus. The antibiotic susceptibility patterns were
similar to the local hospital's outpatient isolates and no dominant
strain was identified by arbitrarily primed polymerase chain reaction
(AB-PCR). Variables significantly and independently associated with
colonization included antibiotic use (odds ratio [OR] = 0.37;
confidence interval[CI] = 0.18-0.77), active inhalational drug use
within the HIV-seropositive population(OR = 2.36; CI = 1.10-5.10) and female gender (OR = 1.97; CI =
1.09-3.57). Characteristics not independently associated included injection drug use, HIV status, and
CD4 count. The association with active inhalational drug use, a novel finding, may reflect alterations in
the integrity of the nasal mucosa. The lack of association between HIV infection and S. aureus
colonization, which is contrary to most previous studies, could be explained by our rigorous control for
confounding variables or by a limited statistical power due to the sample sizes.
Nasal colonization with Staphylococcus aureus is epidemiologically linked to an increased risk of 
subsequent infection (1-9). In parenteral drug users, insulin-injecting diabetic patients, and dialysis
patients, nasal colonization appears to predispose to infection by providing a reservoir from which the
skin is seeded. Frequent needle injections then provide a portal of bacterial entry. Although
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HIV-seropositive populations have been studied, the role HIV infection plays in predisposing patients to
S. aureus infection is not clear. Several studies describe an increased nasal carriage of S. aureus in HIV 
infected groups (10-14). Neutrophils, monocytes, and immunoglobulins from HIV-seropositive patients 
have impaired function against S. aureus(15-17), and several reports document an increased incidence of
S. aureus infection in people with severe HIV infection (18-22). Thus, some evidence and a rationale for
HIV predisposing patients to increased infection rates exist. However, many of the studies of infection
and colonization contained cases with risk factors for S. aureus infection other than HIV disease (i.e.,
injecting drug use [IDU], presence of long-term intravenous catheters, lymphedema from Kaposi's
sarcoma). Not controlling for these confounding variables could have led an overstatement of the role
that HIV seropositivity plays in predisposing patients to S. aureus infection.
Another potential patient characteristic that could predispose to S. aureus infection is noninjecting
drug use. This type of drug use, in particular inhalational drug use, which could alter the integrity of the
nasal mucosa, has not been studied.
Because nasal carriage appears to be an important precondition to infection, identification of
additional characteristics associated with increased carriage would improve our assessment of the risk of
future disease (9). Such studies not only further our understanding of the disease process but also could
allow for targeted preventive intervention. With the exception of the use of topical antimicrobial agents,
limited work has been directed at prevention. The high frequency of S. aureus infections, their severity, 
and the specter of multidrug-resistant isolates underscores the importance of such work.
To further elucidate factors associated with nasal colonization by S. aureus, we studied a
well-characterized group of active and former drug users, both HIV-seropositive and -seronegative, who
were participating in a prospective study of the natural history of HIV infection. This paper describes
nasal colonization data on a cross-section of this cohort. Because this study uses an epidemiologically
well-described cohort of patients and multivariate analyses, it is unique by comparison with past studies
in its ability to identify patient characteristics independently associated with S. aureus colonization. In
addition to assessing colonization status and correlating this to patient characteristics, we determined
the antibiotic susceptibility pattern on all strains and performed DNA strain analysis through arbitrarily
primed polymerase chain reaction (AP-PCR) to determine if a dominant colonizing strain or pattern
existed within the cohort.
METHODS
Population
The study sample was drawn from a cohort of current and former drug addicts recruited for an
ongoing longitudinal study of the natural history of HIV disease from a hospital-affiliated methadone
maintenance program in the Bronx, New York (23). After providing informed consent, patients undergo a
confidential standardized interview that includes questions about their demographics, drug use and
medical history. Detailed information about the type of drug, routes of administration, and frequency of
use is obtained. Drugs used intravenously included heroin, cocaine, and speed (methamphetamines).
Inhalation is defined as snorting but not smoking drugs. Inhaled drugs included heroin, cocaine, and
speedballs, a mixture of heroin and cocaine. Recent drug use is defined as occurring within 6 months of
the interview. Physical examinations are performed, and blood specimens are obtained for HIV antibody
and CD4 lymphocyte counts. Reevaluations with interviews and physical exams are scheduled every 6
months.
From March 1994 to June 1995, additional information regarding recent (within 2 weeks) antibiotic
use was obtained. Swabs of the anterior nares for isolation of S. aureus were collected from consenting 
patients available during periods when laboratory personnel were able to process specimens.
Microbiologic Evaluation
Nasal cultures were obtained by rotating a sterile rayon-tipped swab(Becton Dickinson, Cockeysville,
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MD, U.S.A.) in one anterior nare and placing it in transport media. Subsequent processing of specimens
was done by personnel blinded to clinical information including HIV status. Specimens were plated onto
mannitol-salt agar within 24 hours. Positive plates were numerically graded according to the number of
colonies: 0, no growth; 1, rare positive colonies; 2, many discrete positive colonies; and 3, a lawn of
positive colonies. All positive cultures were confirmed by catalase and the Staphaurex test (Murex
Diagnostics Limited, Dartford, Kent, U.K.), which detects clumping factor and protein A. Antibiotic
susceptibilities were determined via the Kirby-Bauer disk diffusion method. Antibiotics tested included
penicillin, oxacillin, cephalothin, trimethoprim-sulfamethoxazole, erythromycin, clindamycin, rifampin,
ciprofloxacin, vancomycin, gentamicin, and mupirocin. Isolated colonies were grown in Todd-Hewitt
broth (THB) overnight and aliquots frozen in 20% glycerol for future strain typing.
Strain Typing With Arbitrarily Primed Polymerase Chain Reaction
Bacteria from stored aliquots were streaked onto blood agar plates. Single colonies were inoculated
into 5 mL THB and incubated overnight at 37Â°C in a gyroshaker. DNA was extracted from 500 Âµl
using Qiagen tips (Qiagen Inc., Chatsworth, CA, U.S.A.). The manufacturer's protocol was modified for
lysis of S. aureus and included lysostaphin(Applied Microbiology, New York, NY, U.S.A.) at a final
concentration 15 Âµg/ml. M13 reverse sequencing primer(GGAAA-CAGCTATGACCATG) was chosen for
amplification reactions based on its previous use with S. aureus(24). The AP-PCR was performed in
50-Âµl volumes that contained 0.25 U Taq polymerase, single strength Taq buffer (Gibco BRL, Life
Technologies, Gaithersburg, MD, U.S.A.), 2.5 mmol/L of magnesium chloride, 0.2 mmol/L of each
deoxynucleoside triphosphate, 5 ÂµM of primer, and 5 Âµl of template genomic DNA (total template DNA
~100 ng). The amplification procedure was modified from previously published protocols (24). After a
4-minute period at 95Â°C for complete denaturation, 45 low stringency cycles were performed: 94Â°C
for 1 minute for denaturation, 34Â°C for 1 minute for annealing, and 72Â°C for 2 minutes for extension.
Ten microliters of reaction mix was run on an agarose gel electrophoresis at 100 V for 2 hours and
stained with ethidium bromide. Negative controls of reaction mix without template DNA and a positive
control of a laboratory strain (25) were included in all experiments. Isolates were considered distinct if 
they consistently differed by one or more bands (24).
Statistical Analyses
After examining the distributional properties of variables, the statistical relation of each variable to
colonization (binary outcome) was studied. For categorical variables, [chi]2 and Fisher's exact tests were
performed. t-Tests for continuous variables were calculated for normally distributed data or for variables
normally distributed after transformation. Multivariate analyses (logistic regression) were carried out to
examine the independent association of the primary study variables, controlling for potential
confounders. Variables were retained in models if they had a p value of 0.20 or less. Variables were
considered statistically significant at an alpha level of 0.05 (two-sided). OR and their 95% CI were
calculated from regression coefficients and their standard errors in logistic regression models.
RESULTS
As of February 28, 1994, 881 current and former drug users were actively participating in the
longitudinal study of the natural history of HIV disease. From March 1994 to May 1995, 230 patients
were enrolled into the present study. Four specimens had questionable labeling and nine visits were
duplicates; thus, 217 patients were included in the analysis. The demographic characteristics of the
study subjects, listed in Table 1, were not statistically different from the larger longitudinal cohort. The
majority of patients were Hispanic. Thirty-six percent of those studied were women, 35%
HIV-seropositive, 25% were recent injecting drug users, 23% inhalational drug users, and 23% had
taken antibiotics within the past 2 weeks. Of the HIV-seropositive patients, the median CD4 count was
375/Âµl (range, 7-1557/Âµl). Of the 50 inhalational drug users, 33 snorted heroin, 30 snorted cocaine,
and 4 snorted speedballs (a mixture of heroine and cocaine). Antibiotics used included
trimethoprim-sulfamethoxazole(18 patients), penicillin (10 patients), ampicillin (3 patients), amoxicillin
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(2 patients), dicloxicillin(3 patients), cefuroxime (2 patients), amoxicillin-clavulanic acid (1 patient),
erythromycin (3 patient), ciprofloxacin (2 patients), doxycycline (1 patient), and rifabutin (1 patient).
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TABLE 1. Characteristics of subjects cultured for nasal colonization with
Staphylococcus aureus
Of the 217 patients, 89 (41%) had positive nasal cultures for S. aureus. Of these, 73 (82%) were
heavily colonized (plates graded >=2). Single variable analyses revealed an association of colonization
with female gender and antibiotic use. Antibiotic use provided a protective effect (OR = 0.38; CI = 0.17,
0.83). Logistic regression (Table 2) confirmed this finding and also demonstrated the association with
female gender. Inhalational drug use was noted to be significantly and independently associated with
colonization in the HIV-seropositive group. Within the total group, inhalational drug use demonstrated a
trend toward increased colonization. Characteristics not independently associated with colonization
included injection drug use, HIV status, and CD4 count and percentage.
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TABLE 2. Logistic regression analyses: variables associated with positive 
nasal colonization with Staphylococcus aureus
The antibiotic susceptibility patterns of the S. aureus isolates were similar to patterns found with the
local hospital's outpatient S. aureus strains (Table 3). Forty-one randomly selected isolates were
compared by AP-PCR. Although several isolates were similar, most were unique and no dominant strain
was identified. Figure 1 displays a representative sample of isolates.
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TABLE 3. Susceptibility of isolates to antibiotics
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FIG. 1. Arbitrarily primed polymerase chain reaction of representative
strains from the longitudinal study cohort. Lane 1, molecular size
standards; lanes 2 through 8, strains from subjects in the cohort. Strains
in lanes 3 and 5 are similar.
DISCUSSION
Because nasal colonization with S. aureus is an important precondition to infection, investigations of
the factors associated with colonization may shed light on the pathogenesis of S. aureus disease (2-9). In 
this cross-sectional study, S. aureus nasal colonization was independently correlated with use of
antibiotics, inhalational drug use in HIV-seropositive persons, and female gender. Injection drug use,
HIV status, and CD4 count were not independently associated.
The protective effect of antibiotic use is not surprising and is consistent with prior studies (12). The
association of inhalational drug use with nasal colonization has not been previously described and is
intriguing. It confirms the prominent role the nasal mucosa plays in S. aureus pathogenesis. This effect
was independent of antibiotic use, implying that inhalation of drugs may defeat the protective effect of
antibiotics for some individuals. The exact mechanisms by which staphylococci bind to the nasal mucosa
are not known, although studies describe bacteria binding to both epithelial cells and mucin (26-28).
Recent studies of the staphylococcal-mucin binding interaction suggest the presence of specific bacterial
protein receptors for a carbohydrate moiety in mucin (28). Perhaps inhalational drug use alters this
interaction and increases bacterial adherence. Although more work needs to be done to confirm if
colonized inhalational drug users have more infections with S. aureus, this observation provides an 
opportunity to further study the pathogenesis of staphylococcal infections.
The increased colonization in women may relate to estrogen levels as suggested by a study of
women that linked high estrogen levels with increased S. aureus nasal colonization (29). A previous 
survey described increased carriage in black women (30). Alternatively, unknown and uncontrolled 
confounding variables may explain this finding.
The lack of association with injection drug use in our study requires further study. Previous studies
showing an association with injecting drug use did not examine frequency of drug injection or other
routes of drug use (3). In the study by Tuazon and Sheagren (3), recent drug use(<2 weeks) was
correlated with colonization. We defined drug use as occurring within the past 6 months and collected
data on frequency of injection over the entire period.
Surprisingly and contrary to most other studies, we did not demonstrate an association between HIV
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infection and S. aureus colonization. One other study also found no association of bacterial (21% was
staphylococcal) nasopharyngeal colonization and HIV infection (31). However, HIV infection has been
purported to be a risk factor for infection based on several retrospective studies of staphylococcal
infection, one case control study, several cross-sectional colonization investigations, a prospective study
of carriage, and studies documenting impaired immune function against S. aureus(10-22). Similar to
research on other high-risk groups, these previous studies in HIV-seropositive patients demonstrate the
presence of a S. aureus reservoir and subsequent breaks in the body's defense system. However, 
whether HIV infection is an independent predictor of S. aureus colonization and infection remains
unclear. It is possible that other risk factors might explain the increased colonization and infection rates
in these studies. Perhaps because our study rigorously controlled for confounding variables, the
association with HIV infection was not identified. Alternatively, the lack of statistical association in our
study could be due to the limited sample sizes for HIV-seropositive persons with low CD4 counts and no
antibiotic use.
Although we were unable to demonstrate an association between HIV infection and S. aureus
colonization, this issue is clinically relevant. If there is such an association, identifying a subpopulation of
patients to offer prophylaxis might prevent substantial morbidity and mortality from S. aureus
infections. Moreover, a theoretic risk of accelerated HIV replication caused by S. aureus membrane 
constituents activating HIV-1 NF-[kappa]B sites exists (32). Prophylactic intervention has been successful
in dialysis patients (5) and may already be inadvertently occurring in AIDS patients, given the standard 
use of trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia prophylaxis and increased use
of rifabutin and the azolides, azithromycin and clarithromycin, for prophylaxis of Mycobacterium avium
intercellulare. However, development of bacterial resistance remains a potential negative effect of 
long-term antibiotic use (33). At present, sufficient data on appropriate antibiotic prophylaxis do not
exist. Further studies should be done to address the utility and best approach to prevent staphylococcal
infections in this setting.
The AP-PCR fingerprinting analyses demonstrated a heterogeneous group of isolates at the time of
this study. Previous workers have described clonal dissemination resulting in outbreaks of virulent S. 
aureus in the hospital setting (34,35). The potential for such dissemination in a clinic setting clearly
exists. As our HIV population lives longer, they will require more long-term antibiotic use. The risk of a
dominant strain arising under this selective pressure may therefore increase.
Nasal colonization is a fundamental step in the pathogenesis of S. aureus infections. Thus, rigorous
investigations of colonization can provide a better understanding of infection, guide basic science
investigations, and ultimately lead to better prophylaxis and better treatment regimens. In the present
investigation, the ability to study staphylococcal colonization in a demographically well-defined cohort
using sophisticated statistical techniques resulted in several unexpected observations: an association
between colonization and inhalational drug use and a lack of association between colonization and HIV
seropositivity even when stratified by CD4 count. Prospective follow-up to define the long-term effects of
drug use, antibiotics, or HIV infection are clearly warranted.
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